This excerpt from the “Advisory – Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer” issued in January 2022 provides an overview of the Xeljanz drug safety issue, and how the Xeljanz side effects risks may also apply to Olumiant and … [Read more...]
Philips Bi-Level PAP, CPAP, and Mechanical Ventilators Part of Products Recall in June 2021
In connection with a June 2021 Philips products recall, our law firm is investigating possible lawsuits against Philips for patients who have developed cancer or experienced organ failure following toxic exposures from the polyester-based polyurethane (PE-PUR) sound abatement foam component in these recalled Philips products: Philips … [Read more...]
Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis
Asbestos is a carcinogen associated with lung cancer, but few studies have examined the increased risk of lung cancer due to environmental asbestos exposure. We performed a systematic review and meta-analysis to evaluate the association between environmental asbestos exposure and lung cancer. We searched for articles on non-occupational or … [Read more...]
There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020
There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]
What is the link between asbestos and lung cancer?
Asbestos is a material that people have used as insulation since the Industrial Revolution. There are strong associations between asbestos and certain types of cancer, including lung cancer and mesothelioma, which is a type of cancer that affects the mesothelial cells. According to the American Cancer Society, several expert agencies, including … [Read more...]
FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]
Private Settlement Reached in Mesothelioma Case
A private settlement was reached in a mass litigation asbestos case [on July 28, 2020] in Ohio County [(West Virginia)] Circuit Court, meaning a trial set to take place at The Highlands Event Center next week won’t be necessary. Both Ohio County Clerk of Courts Brenda Miller and court employees for Judge Ronald Wilson said details of the … [Read more...]
After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]
EPA finds asbestos poses cancer risks for workers, reigniting calls for ban
The Environmental Protection Agency (EPA) has determined that [ asbestos dust ] poses an unreasonable risk of [ lung cancer and mesothelioma ] to both workers and consumers who inhale it, ramping up pressure on the agency to ban the substance. In a draft risk assessment published this week, the EPA said that workers who inhale [ asbestos dust ] … [Read more...]
Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung
The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]